Post-stroke blood-brain barrier disruption and poor functional outcome in patients receiving thrombolytic therapy
Document Type
Journal Article
Publication Date
7-1-2019
Journal
Cerebrovascular Diseases
Volume
47
Issue
3-4
DOI
10.1159/000499666
Keywords
Blood-brain barrier; Functional outcome; Ischemic stroke; Magnetic resonance imaging; Post-stroke inflammation
Abstract
Background and Purpose: The role played by post-stroke inflammation after an ischemic event in limiting functional recovery remains unclear. One component of post-stroke inflammation is disruption of the blood-brain barrier (BBB). This study examines the relationship between post-stroke BBB disruption and functional outcome. Methods: Acute stroke patients treated with thrombolysis underwent magnetic resonance imaging scanning 24 h and 5 days after their initial event. BBB permeability maps were generated from perfusion weighted imaging. Average permeability was calculated in the affected hemisphere. Good functional outcome, defined as a modified Rankin score of 0 or 1, was compared with average permeability using logistic regression. Results: Of the 131 patients enrolled, 76 patients had the necessary data to perform the analysis at 24 h, and 58 -patients had data for the 5-day assessment. Higher BBB permeability measured at 24 h (OR 0.57; 95% CI 0.33-0.99, p = 0.045) and at 5 days (OR 0.24; 95% CI 0.09-0.66, p = 0.005) was associated with worse functional outcome 1-3 months after the acute ischemic stroke. For every percentage increase in BBB disruption at 5 days, there was a 76% decrease in the chance of achieving a good functional outcome after stroke. Multivariate analysis found this to be independent of age, stroke volume, or clinical stroke severity. Conclusions: Post-stroke BBB disruption appears to be predictive of functional outcome irrespective of stroke size.
APA Citation
Nadareishvili, Z., Simpkins, A., Hitomi, E., Reyes, D., & Leigh, R. (2019). Post-stroke blood-brain barrier disruption and poor functional outcome in patients receiving thrombolytic therapy. Cerebrovascular Diseases, 47 (3-4). http://dx.doi.org/10.1159/000499666